Association of Serum Lipid Levels With HIV Serostatus, Specific Antiretroviral Agents, and Treatment Regimens
Author(s) -
Kathryn Anastos,
Dalian Lu,
Qiuhu Shi,
Phyllis C. Tien,
Robert C. Kaplan,
Nancy A. Hessol,
Steven Cole,
Cheryl Vigen,
Mardge H. Cohen,
Mary Young,
Jessica Justman
Publication year - 2007
Publication title -
jaids journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e318042d5fe
Subject(s) - indinavir , ritonavir , nevirapine , efavirenz , nelfinavir , stavudine , abacavir , medicine , lamivudine , didanosine , serostatus , gastroenterology , immunology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , hepatitis b virus , virus
The effects of HIV infection, highly active antiretroviral therapy (HAART), and specific antiretroviral agents on lipoproteins in women are not well described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom